We show that an adipogenic shift in metabolism associated with TMEM43 and, possibly, other ARVC mutations is critical to the pathogenesis of the clinical phenotype, both electrophysiological and structural. This evidence concerns the gene TMEM43 and Arrhythmogenic right ventricular dysplasia.